Should psychiatrists be prescribing oestrogen therapy to their female patients?

British Journal of Psychiatry

Volumn 202, Issue 1, 2013, Pages 9-13

  Craig, Michael C ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; DYDROGESTERONE; ESTRADIOL; ESTRIOL; ESTRONE; GESTAGEN; GONADORELIN DERIVATIVE; LEVONORGESTREL; NEUROLEPTIC AGENT; NORETHISTERONE; PROGESTERONE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR;

ALZHEIMER DISEASE; ARTICLE; BIPOLAR DEPRESSION; COGNITIVE THERAPY; DRUG MEGADOSE; EPISODIC MEMORY; ESTROGEN THERAPY; FOLLOW UP; HEREDITY; HORMONAL THERAPY; HUMAN; HYSTERECTOMY; MENTAL HEALTH CARE; META ANALYSIS (TOPIC); MINI MENTAL STATE EXAMINATION; MOOD CHANGE; ORAL CONTRACEPTION; OVULATION; PHASE 2 CLINICAL TRIAL (TOPIC); PREMENSTRUAL DYSPHORIC DISORDER; PREMENSTRUAL SYNDROME; PRESCRIPTION; PSYCHIATRIST; PSYCHIATRY; PUERPERAL DEPRESSION; PUERPERAL PSYCHOSIS; PUERPERIUM; RANDOMIZED CONTROLLED TRIAL (TOPIC); SALPINGOOOPHORECTOMY; SCHIZOPHRENIA; TREATMENT DURATION; VERBAL MEMORY;

ALZHEIMER DISEASE; ATTITUDE OF HEALTH PERSONNEL; DEPRESSIVE DISORDER; DISEASE SUSCEPTIBILITY; DRUG PRESCRIPTIONS; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HUMANS; MALE; MENOPAUSE; PHYSICIAN'S PRACTICE PATTERNS; PREMENSTRUAL SYNDROME; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SCHIZOPHRENIA;

EID: 84872155113     PISSN: 00071250     EISSN: 14721465     Source Type: Journal    
DOI: 10.1192/bjp.bp.111.102855     Document Type: Article

References (62)

1. Bloch M, Schmidt PJ, Danaceau M, Murphy J, Nieman L, Rubinow DR. Effects of gonadal steroids in women with a history of postpartum depression. Am J Psychiatry 2000; 157: 924-30.
2. Rubinow DR, Schmidt PJ, Roca CA. Estrogen-serotonin interactions: implications for affective regulation. Biol Psychiatry 1998; 44: 839-50.
3. Payne JL, Roy PS, Murphy-Eberenz K, Weismann MM, Swartz KL, McInnis MG, et al. Reproductive cycle-associated mood symptoms in women with major depression and bipolar disorder. J Affect Disord 2007; 99: 221-9.
4. Stewart DE, Boydell KM. Psychologic distress during menopause: associations across the reproductive life cycle. Int J Psychiatry Med 1993; 23: 157-62.
5. Payne JL, Palmer JT, Joffe H. A reproductive subtype of depression: conceptualizing models and moving toward etiology. Harv Rev Psychiatry 2009; 17: 72-86.
6. Studd JW. A guide to the treatment of depression in women by estrogens. Climacteric 2011; 14: 637-42.
7. Craig MC, Murphy DG. Estrogen therapy and Alzheimer's dementia. Ann N Y Acad Sci 2010; 1205: 245-53.
8. Kulkarni J, de Castella A, Fitzgerald PB, Gurvich CT, Bailey M, Bartholomeusz C, et al. Estrogen in severe mental illness: a potential new treatment approach. Arch Gen Psychiatry 2008; 65: 955-60.
9. Widholm O, Kantero RL. A statistical analysis of the menstrual patterns of 8,000 Finnish girls and their mothers. Acta Obstet Gynecol Scand 1971; 14 (suppl 14): 1-36.
10. Dalton K, Dalton ME, Guthrie K. Incidence of the premenstrual syndrome in twins. BMJ (Clin Res Ed) 1987; 295: 1027-8.
11. Kendler KS, Silberg JL, Neale MC, Kessler RC, Heath AC, Eaves LJ. Genetic and environmental factors in the aetiology of menstrual, premenstrual and neurotic symptoms: a population-based twin study. Psychol Med 1992; 22: 85-100.
12. Condon JT. The premenstrual syndrome: a twin study. Br J Psychiatry 1993; 162: 481-6.
13. Kendler KS, Karkowski LM, Corey LA, Neale MC. Longitudinal population-based twin study of retrospectively reported premenstrual symptoms and lifetime major depression. Am J Psychiatry 1998; 155: 1234-40.
14. Huo L, Straub RE, Roca C, Schmidt PJ, Shi K, Vakkalanka R, et al. Risk for premenstrual dysphoric disorder is associated with genetic variation in ESR1, the estrogen receptor alpha gene. Biol Psychiatry 2007; 62: 925-33.
15. Treloar SA, Martin NG, Bucholz KK, Madden PA, Heath AC. Genetic influences on post-natal depressive symptoms: findings from an Australian twin sample. Psychol Med 1999; 29: 645-54.
16. Forty L, Jones L, Macgregor S, Caesar S, Cooper C, Hough A, et al. Familiality of postpartum depression in unipolar disorder: results of a family study. Am J Psychiatry 2006; 163: 1549-53.
17. Cooper PJ, Campbell EA, Day A, Kennerley H, Bond A. Non-psychotic psychiatric disorder after childbirth. A prospective study of prevalence, incidence, course and nature. Br J Psychiatry 1988; 152: 799-806.
18. O'Hara MW, Zekoski EM, Philipps LH, Wright EJ. Controlled prospective study of postpartum mood disorders: comparison of childbearing and nonchildbearing women. J Abnorm Psychol 1990; 99: 3-15.
19. Cox JL, Murray D, Chapman G. A controlled study of the onset, duration and prevalence of postnatal depression. Br J Psychiatry 1993; 163: 27-31.
20. Gaynes BN, Gavin N, Meltzer-Brody S, Lohr KN, Swinson T, Gartlehner G, et al. Perinatal depression: prevalence, screening accuracy, and screening outcomes. Evid Rep Technol Assess (Summ) 2005; 119: 1-8.
21. Eberhard-Gran M, Eskild A, Tambs K, Samuelsen SO, Opjordsmoen S. Depression in postpartum and non-postpartum women: prevalence and risk factors. Acta Psychiatr Scand 2002; 106: 426-33.
22. Munk-Olsen T, Laursen TM, Pedersen CB, Mors O, Mortensen PB. New parents and mental disorders: a population-based register study. JAMA 2006; 296: 2582-9.
23. Ahokas A, Kaukoranta J, Wahlbeck K, Aito M. Estrogen deficiency in severe postpartum depression: successful treatment with sublingual physiologic 17beta-estradiol: a preliminary study. J Clin Psychiatry 2001; 62: 332-6.
24. Gregoire AJ, Kumar R, Everitt B, Henderson AF, Studd JW. Transdermal oestrogen for treatment of severe postnatal depression. Lancet 1996; 347: 930-3.
25. Craig M, Howard L. Postnatal depression. Clin Evid (Online) 2009; 1: 1407.
26. Sherwin BB, Suranyi-Cadotte BE. Up-regulatory effect of estrogen on platelet 3H-imipramine binding sites in surgically menopausal women. Biol Psychiatry 1990; 28: 339-48.
27. Montgomery JC, Appleby L, Brincat M, Versi E, Tapp A, Fenwick PB, et al. Effect of oestrogen and testosterone implants on psychological disorders in the climacteric. Lancet 1987; 1: 297-9.
28. Welton AJ, Vickers MR, Kim J, Ford D, Lawton BA, MacLennan AH, et al. Health related quality of life after combined hormone replacement therapy: randomised controlled trial. BMJ 2008; 337: a1190.
29. Coope J. Is oestrogen therapy effective in the treatment of menopausal depression? J R Coll Gen Pract 1981; 31: 134-40.
30. Campbell S, Whitehead M. Oestrogen therapy and the menopausal syndrome. Clin Obstet Gynaecol 1977; 4: 31-47.
31. Pearce J, Hawton K, Blake F, Barlow D, Rees M, Fagg J, et al. Psychological effects of continuation versus discontinuation of hormone replacement therapy by estrogen implants: a placebo-controlled study. J Psychosom Res 1997; 42: 177-86.
32. Morrison MF, Kallan MJ, Ten Have T, Katz I, Tweedy K, Battistini M. Lack of efficacy of estradiol for depression in postmenopausal women: a randomized, controlled trial. Biol Psychiatry 2004; 55: 406-12.
33. Cohen LS, Soares CN, Poitras JR, Prouty J, Alexander AB, Shifren JL. Short-term use of estradiol for depression in perimenopausal and postmenopausal women: a preliminary report. Am J Psychiatry 2003; 160: 1519-22.
34. Schmidt PJ, Nieman L, Danaceau MA, Tobin MB, Roca CA, Murphy JH, et al. Estrogen replacement in perimenopause-related depression: a preliminary report. Am J Obstet Gynecol 2000; 183: 414-20.
35. Soares CN, Almeida OP, Joffe H, Cohen LS. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial. Arch Gen Psychiatry 2001; 58: 529-34.
36. Magos AL, Studd JWW. The premenstrual syndrome. In Progress in Obstetrics and Gynaecology (ed. J Studd): 334-50. Churchill Livingstone, 1984.
37. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th edn) (DSM-IV). APA, 1994
38. Klock SC. Premenstrual dysphoric disorder. In Kistner's Gynecology and Women's Health (7th edn) (ed. KJ Ryan): 520-4. Mosby, 1999.
39. Dalton K. The Premenstrual Syndrome and Progesterone Therapy (2nd edn). Year Book Medical Publisher, 1984.
40. Dalton K. Comparative trials of new oral progestogenic compounds in treatment of premenstrual syndrome. Br Med J (Clin Res Ed) 1959; 2: 1307-9.
41. Redei E, Freeman EW. Daily plasma estradiol and progesterone levels over the menstrual cycle and their relation to premenstrual symptoms. Psychoneuroendocrinology 1995; 20: 259-67.
42. Wyatt K, Dimmock P, Jones P, Obhrai M, O'Brien S. Efficacy of progesterone and progestogens in management of premenstrual syndrome: systematic review. BMJ 2001; 323: 776-80.
43. Royal College of Obstetricians and Gynaecologists. Management of Premenstrual Syndrome (Green-top Guideline No. 48). RCOG, 2007.
44. Graham CA, Sherwin BB. A prospective treatment study of premenstrual symptoms using a triphasic oral contraceptive. J Psychosom Res 1992; 36: 257-66.
45. Freeman EW, Kroll R, Rapkin A, Pearlstein T, Brown C, Parsey K, et al. Evaluation of a unique oral contraceptive in the treatment of premenstrual dysphoric disorder. J Womens Health Gend Based Med 2001; 10: 561-9.
46. Coffee AL, Kuehl TJ, Willis S, Sulak PJ. Oral contraceptives and premenstrual symptoms: comparison of a 21/7 and extended regimen. Am J Obstet Gynecol 2006; 195: 1311-9.
47. Pearlstein TB, Bachmann GA, Zacur HA, Yonkers KA. Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation. Contraception 2005; 72: 414-21.
48. Yonkers KA, O'Brien PM, Eriksson E. Premenstrual syndrome. Lancet 2008; 371: 1200-10.
49. Hunter MS, Ussher JM, Browne SJ, Cariss M, Jelley R, Katz M. A randomized comparison of psychological (cognitive behavior therapy), medical (fluoxetine) and combined treatment for women with premenstrual dysphoric disorder. J Psychosom Obstet Gynaecol 2002; 23: 193-9.
50. Jones I, Craddock N. Familiality of the puerperal trigger in bipolar disorder: results of a family study. Am J Psychiatry 2001; 158: 913-7.
51. Heron J, Robertson Blackmore E, McGuinness M, Craddock N, Jones I. No 'latent period' in the onset of bipolar affective puerperal psychosis. Arch Womens Ment Health 2007; 10: 79-81.
52. Robertson E, Jones I, Haque S, Holder R, Craddock N. Risk of puerperal and non-puerperal recurrence of illness following bipolar affective puerperal (post-partum) psychosis. Br J Psychiatry 2005; 186: 258-9.
53. Jones I, Craddock N. Searching for the puerperal trigger: molecular genetic studies of bipolar affective puerperal psychosis. Psychopharmacol Bull 2007; 40: 115-28.
54. Sichel DA, Cohen LS, Robertson LM, Ruttenberg A, Rosenbaum JF. Prophylactic estrogen in recurrent postpartum affective disorder. Biol Psychiatry 1995; 38: 814-8.
55. Ahokas A, Aito M, Rimon R. Positive treatment effect of estradiol in postpartum psychosis: a pilot study. J Clin Psychiatry 2000; 61: 166-9.
56. Kumar C, McIvor RJ, Davies T, Brown N, Papadopoulos A, Wieck A, et al. Estrogen administration does not reduce the rate of recurrence of affective psychosis after childbirth. J Clin Psychiatry 2003; 64: 112-8.
57. Craig MC, Cutter WJ, Norbury R, Murphy DGM. X chromosome, estrogen and brain development: implications for schizophrenia. In Neurodevelopment and Schizophrenia (eds M Keshavan, JL Kennedy, R Murray): 330-46. Cambridge University Press, 2005.
58. Chua WL, de Izquierdo SA, Kulkarni J, Mortimer A. Estrogen for schizophrenia. Cochrane Database Syst Rev 2005; 4: CD004719.
59. Hogervorst E, Yaffe K, Richards M, Huppert FA. Hormone replacement therapy to maintain cognitive function in women with dementia. Cochrane Database Syst Rev 2009; 1: CD003799.
60. Craig MC, Maki PM, Murphy DGM. The Women's Health Initiative Memory Study: findings and implications for treatment. Lancet Neurol 2005; 4: 1-5.
61. British Medical Association & Royal Pharmaceutical Society. 6.4.1.1 Oestrogens and HRT. In British National Formulary 63 (March 2012): 470-7. British Pharmaceutical Press, 2012.
62. Craig MC, Brammer M, Maki PM, Fletcher PC, Daly EM, Rymer J, et al. The interactive effect of acute ovarian suppression and the cholinergic system on visuospatial working memory in young women. Psychoneuroendocrinology 2010; 35: 987-1000.